1. Home
  2. EYPT vs SHEN Comparison

EYPT vs SHEN Comparison

Compare EYPT & SHEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • SHEN
  • Stock Information
  • Founded
  • EYPT 1987
  • SHEN 1902
  • Country
  • EYPT United States
  • SHEN United States
  • Employees
  • EYPT N/A
  • SHEN N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • SHEN Telecommunications Equipment
  • Sector
  • EYPT Industrials
  • SHEN Telecommunications
  • Exchange
  • EYPT Nasdaq
  • SHEN Nasdaq
  • Market Cap
  • EYPT 741.0M
  • SHEN 726.3M
  • IPO Year
  • EYPT 2005
  • SHEN N/A
  • Fundamental
  • Price
  • EYPT $14.00
  • SHEN $13.35
  • Analyst Decision
  • EYPT Strong Buy
  • SHEN Strong Buy
  • Analyst Count
  • EYPT 6
  • SHEN 1
  • Target Price
  • EYPT $25.83
  • SHEN $26.00
  • AVG Volume (30 Days)
  • EYPT 1.1M
  • SHEN 310.3K
  • Earning Date
  • EYPT 11-06-2025
  • SHEN 11-06-2025
  • Dividend Yield
  • EYPT N/A
  • SHEN 0.73%
  • EPS Growth
  • EYPT N/A
  • SHEN N/A
  • EPS
  • EYPT N/A
  • SHEN N/A
  • Revenue
  • EYPT $51,898,000.00
  • SHEN $349,477,000.00
  • Revenue This Year
  • EYPT N/A
  • SHEN $11.97
  • Revenue Next Year
  • EYPT N/A
  • SHEN $9.07
  • P/E Ratio
  • EYPT N/A
  • SHEN N/A
  • Revenue Growth
  • EYPT 2.99
  • SHEN 20.36
  • 52 Week Low
  • EYPT $3.91
  • SHEN $9.77
  • 52 Week High
  • EYPT $14.91
  • SHEN $16.28
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 58.99
  • SHEN 49.28
  • Support Level
  • EYPT $13.00
  • SHEN $13.20
  • Resistance Level
  • EYPT $14.04
  • SHEN $13.80
  • Average True Range (ATR)
  • EYPT 0.93
  • SHEN 0.37
  • MACD
  • EYPT -0.08
  • SHEN -0.00
  • Stochastic Oscillator
  • EYPT 62.87
  • SHEN 41.88

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Company, with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

Share on Social Networks: